Filing Flows › Comparisons › VRCA vs QURE
Verrica Pharmaceuticals vs uniQure N.V.: VRCA and QURE compared
Verrica Pharmaceuticals is the larger company: $5.9M of revenue in its latest quarter (Q2 2026) against $5.2M for uniQure N.V. (Q3 2026). uniQure N.V. is growing faster (+40% against -54% a year earlier).
Where the money goes: VRCA and QURE
Verrica Pharmaceuticals (VRCA) · Q2 2026
Verrica Pharmaceuticals, Q2 2026: revenue $5.9M (-54% year over year), operating margin -223.4%, net loss $13.2M, operating cash flow −$9.3M. The chart follows the revenue to costs, profit and cash.
uniQure N.V. (QURE) · Q3 2026
uniQure N.V., Q3 2026: revenue $5.2M (+40% year over year), net loss $61.2M, operating cash flow −$47.8M. The chart follows the revenue to costs, profit and cash.
| Verrica Pharmaceuticals (VRCA) | uniQure N.V. (QURE) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $5.9M | $5.2M |
| Revenue growth, Y/Y | -54% | +40% |
| Operating margin | -223.4% | n/m |
| Net earnings | −$13.2M | −$61.2M |
| Net margin | -224.4% | — |
| Operating cash flow | −$9.3M | −$47.8M |
Questions
Which is bigger, Verrica Pharmaceuticals or uniQure N.V.?
Verrica Pharmaceuticals is the larger company: $5.9M of revenue in its latest quarter (Q2 2026) against $5.2M for uniQure N.V. (Q3 2026).
Is Verrica Pharmaceuticals or uniQure N.V. growing faster?
uniQure N.V. is growing faster (+40% against -54% a year earlier).
More: Verrica Pharmaceuticals earnings · how Verrica Pharmaceuticals makes money · uniQure N.V. earnings · how uniQure N.V. makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 6, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.